Drugs and Devices

FDA issues proposed guidelines for developing drugs for Alzheimer’s disease

On Feb. 7, 2013, the U.S. Food and Drug Administration (FDA) issued a proposal designed to help companies developing new treatments for patients in the early stages of Alzheimer’s disease. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares